Letter to the Editor

An Update of Anticoagulant Strategies in Noncritically Ill Patients Hospitalized with COVID-19

Abstract

No Abstract No Abstract No Abstract

ATTACC Investigators; ACTIV-4a Investigators; REMAP-CAP Investigators; Lawler PR, Goligher EC, Berger JS, et al. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. N Engl J Med 2021;385:790-802.
Pilia E, Belletti A, Fresilli S, Lee TC, Zangrillo A, Finco G, Landoni G; full anticoagulation. The Effect of Heparin Full-Dose Anticoagulation on Survival of Hospitalized, Non-critically Ill COVID-19 Patients: A Meta-analysis of High Quality Studies. Lung 2023;201:135-147.
Stone GW, Farkouh ME, Lala A, Tinuoye E, Dressler O, Moreno PR, Palacios IF, Goodman SG, Esper RB, Abizaid A, Varade D, Betancur JF, Ricalde A, Payro G, Castellano JM, Hung IFN, Nadkarni GN, Giustino G, Godoy LC, Feinman J, Camaj A, Bienstock SW, Furtado RHM, Granada C, Bustamante J, Peyra C, Contreras J, Owen R, Bhatt DL, Pocock SJ, Fuster V; FREEDOM COVID Anticoagulation Strategy Randomized Trial Investigators. Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19. J Am Coll Cardiol 2023;81:1747-1762.
Files
IssueVol 19 No 2 (2024): J Teh Univ Heart Ctr QRcode
SectionLetter to the Editor
DOI https://doi.org/10.18502/jthc.v19i2.16208
Keywords
COVID-19 Anticoagulation Thromboembolic Event

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Iranian M, Rostamkolaei S. An Update of Anticoagulant Strategies in Noncritically Ill Patients Hospitalized with COVID-19. J Tehran Heart Cent. 2024;19(2):151-152.